3KANNEL W B,ABBOTT R D,SAVAGE D D,et al.Epidemiologic Features of Chronic Atrial Fibrillation[J].New Engl J Med,1982,306:1018-1022.
4FUSTER V,RYDEN L E,CANNOM D S,et al.2011ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation:a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J].Circulation,2011,123:e269-e367.
5MCNAMARA R L,TAMARIZ L J,SEGAL J B,et al.Management of atrial fibrillation:review of the evidence for the role of pharmacologic therapy,electrical cardioversion,and echocardiography[J].Ann Intern Med,2003,139:1018-1033.
6JANUARY C T,WANN L S,ALPERT J S,et al.2014AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J].J Am Coll Cardiol,2014,64:e1-e76.
7MARTINEZ-MARCOS F J,GARCIA-GARMENDIA J L,ORTEGA-CARPIO A,et al.Comparison of intravenous flecainide,propafenone,and amiodarone for conversion of acute atrial fibrillation to sinus rhythm[J].Am J Cardiol,2000,86:950-953.
8CHEN D Y,CAO J,ZHU B P,et al.Drug theraphy of paroxysmal atrial fibrillation in the elderly over 75years old[J].Chin Med Sci J,2016,21:16-19.
9BALLA I,PETRELA E,KONDILI A.Pharmacological conversion of recent atrial fibrillation:a randomized,placebo-controlled study of three antiarrhythmic drugs[J].Anadolu Kardiyol Derg,2011,11:600-606.
10BLANC J J,VOINOV C,MAAREK M.Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation.PARSIFAL Study Group[J].Am J Cardiol,1999,84:1029-1032.
